Peqish Group Achieves Major Milestone with INCI Name Assignment for Derma-QI™
Vancouver, Canada
Imagine a botanical extract that could bridge science and skincare. Peqish has taken a major step to make that a reality with the INCI designation of its proprietary extract Derma-QI™. Derived from Peqish’s Phyto-P™ powder, Derma-QI™ is a patent pending, science backed-botanical extract designed for sensitive skin. Packed with polyphenols, powerful antioxidant compounds, these compounds are known to calm redness, fight free-radicals, and reduce hyperpigmentation, bringing natural botanicals into everyday skincare.
What is INCI and Why It Matters
In a $155 billion global skincare industry, trust and transparency matter. Varying markets, different languages and long, complex ingredient lists make buying cosmetic products confusing. To address this, the Personal Care Products Council developed the International Nomenclature of Cosmetic Ingredients (INCI), a universal system that ensures consistency and clarity for formulators, regulators and consumers.
“Securing an INCI name is a critical step in our commercialization roadmap,” said Dr. Anthony Marotta, PhD CEO and CSO. “It reinforces our commitment to innovation, safety, and global market readiness, while building confidence with our customers, partners, and investors.”
Global Market Potential
Peqish’s Derma-QI™ is now officially recognized in the INCI as Lactuca Sativa Leaf Extract (monograph ID: 40675). This designation not only validates Derma-QI™’s quality and transparency, but provides a pathway for use in skincare globally, introducing a more natural approach to cosmetics.
This achievement marks a major milestone in Peqish’s growth as a science-driven wellness company, driven to turning advanced research into safe and effective solutions for the global market.
Additionally, INCI assignment lists Derma-QI™ in the International Cosmetic Ingredient Dictionary and Handbook, the web-based Dictionary wINCI, and the Council’s On-Line INFOBASE, making it accessible to formulators and regulatory bodies worldwide.
As Peqish continues to grow its footprint in the high-growth skincare and wellness markets, this achievement underscores the company’s ability to translate proprietary research into globally recognized, market-ready solutions.
About Peqish Group
Peqish Group is an ag-tech company on a mission to turn revolutionary science into real solutions for better health. They blend cutting-edge technology with a deep scientific and clinical understanding to create products that not only manage conditions, but help prevent and resolve them. From the research to the launch, Peqish’s team is dedicated to supporting a healthier, more sustainable future where people reach optimal health naturally. Learn more about Peqish Group at www.peqishgroup.com and follow us on LinkedIn.
Forward Looking Statements
This news release includes forward-looking statements, which relate to future events, expectations and potential outcomes of the company. This includes words like"anticipate", "believe", "plan", "estimate", "expect", and "intend", or phrases such as "may", "might", "could", "should", or "will" when referring to actions or events that haven’t happened yet. These statements are based on assumptions and expectations, and as with any future statement, there are risks and uncertainties involved. Actual results and outcomes may be different due to unpredictable factors like market changes, funding needs, competing priorities, and changes in share prices. We make these statements based on the information we have now, at the time of writing, and aren’t obligated to update them unless required by law. Investors should be cautious about putting too much certainty on forward-looking statements.
Media Contact
Dr. Anthony Marotta, PhD.
info@peqish.com